Peter Ruane, MD

Ruane Clinical Research, Los Angeles, CA, USA
Los Angeles, California, United States

Disclosure information not submitted.

Presentation(s):

• 129 - Pooled safety and tolerability of twice-yearly lenacapavir with teropavimab and zinlirvimab for HIV-1 treatment

  Monday, October 20, 2025
  12:30 PM - 12:35 PM US ET

• 172 - The First Proof-of-Concept Clinical Trial of an HIV-1 Allosteric Integrase Inhibitor, Pirmitegravir (STP0404)

  Monday, October 20, 2025
  1:57 PM - 2:09 PM US ET